Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, ‘We have become proud to be supplying our H1N1 vaccine to the Chinese federal government and are confident that we can complete the nationwide H1N1 vaccine stockpiling job in a timely manner. We continue to work towards our objective of providing citizens of China with affordable, international-quality vaccines. The contract with the Shanghai Municipal Center for Disease Control and Prevention brings us closer to our goal as it opened up another important public market in China.’.. China places third purchase order for H1N1 vaccine with Sinovac Biotech Sinovac Biotech Ltd. , a leading provider of biopharmaceutical items in China, announced today that it provides received its third purchase purchase for its H1N1 vaccine, PANFLU.1, from China’s Ministry of Market and Information Technology for the national stockpiling strategy.The neighborhood is well-suited as a backdrop for SIR Spa – Chicago’s premier day spa catering solely to males, and for the spa’s association with Olmetti, whose striking functions are engaged as SIR Spa’s signature showcase through the Oct. 2-4 weekend. Related StoriesNew study discovers high prevalence of HIV among pregnant refugee women in OntarioGenvoya accepted as complete routine for HIV treatmentStudy evaluates efficiency of antiretroviral treatment in HIV-contaminated childrenDuring the Arts weekend, over 25 of Olmetti’s works and installations will be presented at SIR Spa.